ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in multiple therapeutic fields, announced positive topline results from a Phase I trial of ACM-001, the Company’s first clinical-stage development program.
September 5, 2023
· 4 min read
